News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,018 Results
Type
Article (39150)
Company Profile (283)
Press Release (648585)
Section
Business (203902)
Career Advice (1996)
Deals (35372)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344645)
Policy (32450)
Tag
Academia (2530)
Alliances (49186)
Alzheimer's disease (1262)
Approvals (16060)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (189)
Cancer (1375)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64707)
Collaboration (485)
Compensation (262)
COVID-19 (2541)
C-suite (109)
Data (1391)
Diabetes (176)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110014)
Executive appointments (397)
FDA (16785)
Funding (431)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16344)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7862)
Lung cancer (198)
Manufacturing (207)
Medical device (13213)
Medtech (13218)
Mergers & acquisitions (19195)
Metabolic disorders (460)
Neuroscience (1583)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1700)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (56462)
Phase I (20127)
Phase II (28498)
Phase III (21240)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5890)
Regulatory (21679)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1468)
Startups (3562)
United States (15234)
Vaccines (564)
Weight loss (182)
Date
Today (126)
Last 7 days (587)
Last 30 days (2374)
Last 365 days (35285)
2024 (35126)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37275)
Australia (6087)
California (3830)
Canada (1457)
China (307)
Colorado (172)
Connecticut (178)
Europe (79832)
Florida (537)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (634)
Massachusetts (2972)
Michigan (175)
Minnesota (291)
New Jersey (1108)
New York (1091)
North Carolina (743)
Northern California (1700)
Ohio (146)
Pennsylvania (928)
South America (1092)
Southern California (1468)
Texas (554)
Utah (108)
Washington State (401)
688,018 Results for "inflammatix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
November 11, 2024
·
5 min read
Press Releases
Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team
October 10, 2024
·
5 min read
Press Releases
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
September 12, 2024
·
6 min read
Press Releases
Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerity™ Test Regardless of Patient Immune Status
October 1, 2024
·
5 min read
Biotech Bay
Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System
Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development for its TriVerity™ Acute Infection and Sepsis Test System, which includes the Myrna™ Instrument, and for the TriVerity™ Cartridge.
November 15, 2023
·
3 min read
FDA
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
Inflammatix, Inc. announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead product, the TriVerity™ Acute Infection and Sepsis Test System.
November 28, 2023
·
5 min read
Business
Inflammatix Appoints Heiner Dreismann as New Board Member
Inflammatix, a pioneering molecular diagnostics company, announced the appointment of Heiner Dreismann, PhD, as a member of the company’s board of directors.
July 10, 2023
·
2 min read
Business
Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer
Inflammatix, Inc., a pioneering molecular diagnostics company, announced today the appointment of Purvesh Khatri, PhD, as Chief Scientific Officer.
June 15, 2022
·
2 min read
Business
Inflammatix Appoints Dr. Kian Beyzavi as New Board Member
Inflammatix announced today the appointment of Kian Beyzavi, PhD, as an independent member of the company’s board of directors.
November 30, 2021
·
2 min read
Biotech Bay
Inflammatix Awarded $1.7 Million Grant From National Institutes of Health (NIH)
Inflammatix has awarded the company a Small Business Innovation Research (NIH SBIR) Direct-to-Phase II grant of $1.7 million.
November 11, 2021
·
3 min read
1 of 68,802
Next
